TTAB Extensions of Time to Oppose 99371705
USPTO Extensions of Time to Oppose proceeding 99371705, filed 2026-05-13. Status: Not Instituted.
Proceeding Facts
| Proceeding Number | 99371705 |
|---|---|
| Type | Extensions of Time to Oppose |
| Status | Not Instituted |
| Filing Date | 2026-05-13 |
| Last Activity | 2026-05-13 |
| Days Active | 6 |
Parties
- Polyrizon Ltd. — Defendant
- GlaxoSmithKline Biologicals, S.A. — Plaintiff
Plaintiff Marks
- No plaintiffs on record.
Defendant Marks
- NASARIX — Polyrizon Ltd.
Recent Documents
- 2026-05-13: EXT GRANTED — Extensions
- 2026-05-13: FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE — Extensions
Related Proceedings
Other TTAB proceedings involving at least one of the same parties:
- Proceeding 91305794 — Oppositions — Pending (last activity 2026-03-10)
- Proceeding 99204016 — Extensions of Time to Oppose — Terminated (last activity 2026-03-10)
- Proceeding 99171000 — Extensions of Time to Oppose — Terminated (last activity 2025-12-18)
- Proceeding 98548372 — Extensions of Time to Oppose — Terminated (last activity 2025-06-06)
- Proceeding 97411368 — Extensions of Time to Oppose — Terminated (last activity 2025-02-25)